Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varenicline vs Zyban for Smoking Cessation
NCT00141206Phase 3Completed
- Sponsor
- Pfizer
- Start
- May 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of varenicline in nicotine dependence (3 arms), sponsored by Pfizer. Primary endpoint: 4 week Continuous Quit Rate for weeks 9-12 at 12 weeks. Started May 2003; status: completed.
02
Drugs
varenicline
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT00141206.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00141206.